Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TDP2 Antikörper

Dieses Maus Monoklonal-Antikörper erkennt spezifisch TDP2 in WB und FACS. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN2704362

Kurzübersicht für TDP2 Antikörper (ABIN2704362)

Target

Alle TDP2 Antikörper anzeigen
TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))

Reaktivität

  • 48
  • 31
  • 9
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Wirt

  • 48
  • 15
Maus

Klonalität

  • 50
  • 13
Monoklonal

Konjugat

  • 28
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser TDP2 Antikörper ist unkonjugiert

Applikation

  • 48
  • 26
  • 26
  • 22
  • 20
  • 13
  • 13
  • 11
  • 8
  • 6
  • 3
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS)

Güteklasse

GMP Grade

Klon

42c
  • Verwendungszweck

    Anti-EAPII Unconjugated Antibody

    Produktmerkmale

    EAPII (also called TTRAP, TDP2) originally was identified as an interacting partner of oncogene ETS1, a founding member of ets transcription factor, and the cytoplasmic domain of CD40, a member of the tumor necrosis factor (TNF) receptor family. EAPII significantly represses ETS1 transcriptional activity and the synergistic transactivation by ETS1 and AP-1 or by ETS1 and NFκB. EAPII/TTRAP also inhibits the transcriptional activation of NFB induced by CD40 or phorbol 12-myristate 13-acetate (PMA). Recently this protein was also proven to be the first 5'- tyrosyl-DNA phosphodiesterase. EAPII has been demonstrated to have promiscuous protein associations, broad responsiveness to various extracellular signals, and pleiotropic functions in the development of human diseases including cancer and neurodegenerative disease. Emerging data suggest that EAPII is a multi-functional protein: it repairs enzyme (topoisomerase)-mediated DNA damage by removing phosphotyrosine from DNA adducts, involves in multiple signal transduction pathways such as TNF-TNFR, TGFβ and MAPK, and responsive to immune defense including inflammatory response, viral infection and DNA toxins (chemo or radiation therapy). EAPII predominantly localizes to the nucleus, but based on pathological conditions it also localizes in both cytoplasm and nucleus.

    Aufreinigung

    Purified

    Reinheit

    >95 %

    Immunogen

    Recombinant full length protein

    Isotyp

    IgG2b, kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    0.5 mg/mL

    Buffer

    PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C
  • Target

    TDP2 (tyrosyl-DNA phosphodiesterase 2 (TDP2))

    Andere Bezeichnung

    EAPII

    NCBI Accession

    NM_016614

    UniProt

    O95551
Sie sind hier:
Chat with us!